Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Market Analysis & Valuation

UpdatedFeb 12, 2026
DataAggregated Company Financials
Companies132
  • 7D-0.5%
  • 3M3.5%
  • 1Y-21.5%
  • YTD-0.5%

Over the last 7 days, the market has dropped 5.3%, driven by a decline of 12% in the Healthcare sector. In contrast, the Consumer Staples sector has actually gained 8.1%. As for last year, the market is also down 22%. As for the next few years, earnings are expected to grow by 5.7% per annum.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Danish Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 12 Feb 2026DKK 4.2tDKK 2.0tDKK 241.9b16x17.2x2.1x
Sat, 10 Jan 2026DKK 4.5tDKK 2.0tDKK 261.1b16.5x17.1x2.3x
Mon, 08 Dec 2025DKK 4.0tDKK 2.0tDKK 261.7b14.3x15.5x2.1x
Wed, 05 Nov 2025DKK 4.0tDKK 2.0tDKK 286.9b14.7x13.8x2x
Fri, 03 Oct 2025DKK 4.0tDKK 1.9tDKK 287.4b14.9x13.9x2.1x
Sun, 31 Aug 2025DKK 4.0tDKK 1.9tDKK 287.0b15x14x2.1x
Tue, 29 Jul 2025DKK 4.5tDKK 1.9tDKK 262.2b16.1x17.2x2.4x
Thu, 26 Jun 2025DKK 4.4tDKK 1.9tDKK 262.1b15.2x16.6x2.3x
Sat, 24 May 2025DKK 4.4tDKK 1.9tDKK 264.0b15.9x16.7x2.4x
Mon, 21 Apr 2025DKK 4.2tDKK 1.9tDKK 258.7b13.8x16.1x2.2x
Wed, 19 Mar 2025DKK 5.0tDKK 1.9tDKK 260.1b15.5x19.2x2.7x
Fri, 14 Feb 2025DKK 5.0tDKK 1.9tDKK 263.9b13.7x19.1x2.7x
Sun, 12 Jan 2025DKK 5.3tDKK 1.8tDKK 238.8b13.8x22.2x2.9x
Tue, 10 Dec 2024DKK 6.0tDKK 1.8tDKK 237.6b14.1x25.3x3.3x
Thu, 07 Nov 2024DKK 5.8tDKK 1.8tDKK 232.1b14.4x25.2x3.3x
Sat, 05 Oct 2024DKK 6.0tDKK 1.7tDKK 180.3b15.7x33.3x3.4x
Mon, 02 Sep 2024DKK 6.7tDKK 1.7tDKK 180.3b15.3x37.4x3.9x
Wed, 31 Jul 2024DKK 6.6tDKK 1.7tDKK 185.7b15.5x35.4x3.8x
Fri, 28 Jun 2024DKK 7.0tDKK 1.7tDKK 184.8b15.8x37.7x4.1x
Sun, 26 May 2024DKK 6.7tDKK 1.7tDKK 184.6b15.4x36.2x3.9x
Tue, 23 Apr 2024DKK 6.3tDKK 1.7tDKK 192.9b15.2x32.7x3.7x
Thu, 21 Mar 2024DKK 6.5tDKK 1.7tDKK 191.9b14.2x34x3.8x
Sat, 17 Feb 2024DKK 6.3tDKK 1.7tDKK 190.3b13.8x33.1x3.7x
Mon, 15 Jan 2024DKK 5.8tDKK 1.8tDKK 216.6b13.6x26.6x3.2x
Wed, 13 Dec 2023DKK 5.2tDKK 1.8tDKK 217.5b13.3x24.1x2.9x
Fri, 10 Nov 2023DKK 5.3tDKK 1.8tDKK 218.4b12.4x24.3x3x
Sun, 08 Oct 2023DKK 5.2tDKK 1.9tDKK 284.5b13.1x18.4x2.8x
Tue, 05 Sep 2023DKK 5.4tDKK 1.9tDKK 283.7b13.4x19x2.9x
Thu, 03 Aug 2023DKK 5.0tDKK 1.9tDKK 324.1b13.4x15.4x2.6x
Sat, 01 Jul 2023DKK 5.1tDKK 1.9tDKK 322.2b13.8x15.8x2.6x
Mon, 29 May 2023DKK 5.2tDKK 1.9tDKK 325.2b14.2x16x2.7x
Wed, 26 Apr 2023DKK 5.1tDKK 1.9tDKK 343.5b15.1x14.8x2.7x
Fri, 24 Mar 2023DKK 4.8tDKK 1.9tDKK 345.3b13.4x13.9x2.5x
Sun, 19 Feb 2023DKK 4.8tDKK 1.9tDKK 347.0b14.2x13.8x2.5x
Price to Earnings Ratio

13.8x


Total Market Cap: DKK 4.8tTotal Earnings: DKK 347.0bTotal Revenue: DKK 1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Market Price to Earnings3Y Average 22.3x202420252026
Current Market PE
  • Investors are pessimistic on the Danish market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 17.4x which is lower than its 3-year average PE of 22.3x.
Past Earnings Growth
  • The earnings for Danish listed companies have declined 11% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the Danish Market?

DK Market-0.49%
Utilities7.34%
Consumer Staples5.52%
Energy4.86%
Telecom4.57%
Real Estate1.25%
Materials0.67%
Consumer Discretionary0.40%
Financials0.29%
Healthcare-1.23%
Industrials-2.24%
Tech-5.68%
Sector PE
  • Investors favour the Utilities sector the most for future growth which is trading above its 3-year average PE ratio.
    • This is likely because analysts are expecting annual earnings growth of 26.2% and investors are willing to pay a premium for that growth.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 35% over the next 5 years.
  • This is better than its past earnings decline of 17% per year.
  • In contrast, the Energy sector is expected to see its earnings decline by 21% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
ORSTED ØrstedDKK 152.007.3%
+DKK 13.7b		-48.0%PE116.3xUtilities
DSV DSVDKK 1.90k2.8%
+DKK 12.2b		32.5%PE53.9xIndustrials
CARL B CarlsbergDKK 992.807.6%
+DKK 9.3b		20.0%PE22xConsumer Staples
NOVO B Novo NordiskDKK 306.700.7%
+DKK 8.9b		-47.6%PE13.3xHealthcare
DANSKE Danske BankDKK 339.302.1%
+DKK 6.0b		45.3%PB1.5xFinancials
See more

Market Insights

Header cover image
Why alternative investments are making a splash 🖼️
Richard Bowman avatar
Richard Bowman
|
|
Is it the time to invest in alternatives? Here's how you can get exposure.
Continue reading
Why longer lifespans could reshape portfolios 🧓
Last Week

Why longer lifespans could reshape portfolios 🧓

Latest News

VWS
DKK 158.50
Vestas Wind Systems
7D
-17.9%
1Y
57.4%
CARL B
DKK 992.80
Carlsberg
7D
7.6%
1Y
20.0%

Carlsberg's (CPH:CARL B) Conservative Accounting Might Explain Soft Earnings

Feb 12
Carlsberg's (CPH:CARL B) Conservative Accounting Might Explain Soft Earnings
CHEMM
DKK 395.00
ChemoMetec
7D
-31.8%
1Y
-30.8%
DSV
DKK 1,902.50
DSV
7D
2.8%
1Y
32.5%

DSV: Higher Freight Cycle Hopes And Synergies Will Shape Future Returns

The analyst price target for DSV has been raised from DKK 1,901.25 to DKK 2,030.45. This reflects updated assumptions on revenue growth, profit margins and long-term P/E, along with recent price target increases from multiple research houses, according to analysts.
DEMANT
DKK 179.70
Demant
7D
-7.6%
1Y
-30.4%
COLO B
DKK 489.00
Coloplast
7D
-9.5%
1Y
-38.5%

COLO B: Reset P/E And Dividend Will Support Future Upside

Analysts have trimmed their fair value estimate for Coloplast from DKK 678.22 to DKK 615.06, reflecting recent price target cuts and updated assumptions on the discount rate, revenue growth, profit margins and future P/E multiples. Analyst Commentary Recent Street research on Coloplast has focused on recalibrating expectations rather than fundamentally changing the story.
DANSKE
DKK 339.30
Danske Bank
7D
2.1%
1Y
45.3%

Danske Bank's (CPH:DANSKE) Dividend Will Be Increased To DKK22.72

Feb 10
Danske Bank's (CPH:DANSKE) Dividend Will Be Increased To DKK22.72
ZEAL
DKK 403.40
Zealand Pharma
7D
-6.3%
1Y
-43.1%

ZEAL: Metabolic Collaboration Will Drive Future Upside As Profitability Assumptions Improve

Analysts have trimmed their price target for Zealand Pharma from €745.93 to €735.27, reflecting updated assumptions around the discount rate, revenue growth, profit margin and future P/E that modestly adjust their overall valuation framework. What's in the News Zealand Pharma and OTR Therapeutics entered a multi program collaboration and license agreement focused on discovering and developing novel therapeutics for metabolic diseases, combining Zealand Pharma's obesity and metabolic health expertise with OTR Therapeutics' R&D platform (Key Developments).
FLS
DKK 611.00
FLSmidth
7D
10.3%
1Y
63.7%

FLS: March Capital Markets Day Will Test Recently Elevated Expectations

Analysts have raised their price target on FLSmidth from about DKK 500 to around DKK 515, pointing to recent research that highlights the upcoming March capital markets day as a key near term catalyst despite the Q3 miss. Analyst Commentary Bullish Takeaways Bullish analysts point to the higher price targets, such as the move to DKK 540 from DKK 510, as a sign that they see room for improved valuation despite the recent Q3 miss.
PNDORA
DKK 534.40
Pandora
7D
4.3%
1Y
-59.7%

Pandora (CPH:PNDORA) Is Increasing Its Dividend To DKK22.00

Feb 09
Pandora (CPH:PNDORA) Is Increasing Its Dividend To DKK22.00
MAERSK B
DKK 15,205.00
A.P. Møller - Mærsk
7D
-4.8%
1Y
26.0%

MAERSK B: Margin Pressure And Transport Cycle Weakness Will Cap Share Upside

Analysts have trimmed their fair value estimate for A.P. Møller - Mærsk from DKK 8,478.71 to about DKK 7,978.98. This reflects a mix of recent target cuts and upgrades as they factor in softer margins, a slightly smaller expected revenue decline, a higher discount rate, and a very high future P/E assumption from recent research.
NOVO B
DKK 306.70
Novo Nordisk
7D
0.7%
1Y
-47.6%

Novo Nordisk (CPH:NOVO B) Is Paying Out A Larger Dividend Than Last Year

Feb 08
Novo Nordisk (CPH:NOVO B) Is Paying Out A Larger Dividend Than Last Year
ORSTED
DKK 152.00
Ørsted
7D
7.3%
1Y
-48.0%
TRYG
DKK 151.90
Tryg
7D
-3.2%
1Y
1.9%

TRYG: Recent Downgrade And Buyback Will Reset Expectations While Preserving Core Franchise

Analysts have nudged their price target for Tryg slightly higher to €172.90 from €171.59, citing updated assumptions for discount rate, revenue growth, profit margin, and future P/E following recent research, including a downgrade at Barclays. Analyst Commentary Analysts have taken a closer look at Tryg following the recent downgrade, updating their models and risk assessments around valuation and execution.
GMAB
DKK 1,881.50
Genmab
7D
-6.3%
1Y
37.0%

GMAB: Phase 3 Data, AI Adoption And 2026 Readout Will Shape Outlook

Genmab’s analyst fair value estimate has moved modestly higher to DKK 2,188.94. Analysts point to updated assumptions around slightly lower discount rates, adjusted revenue growth and profit margin expectations, and a recalibrated future P/E multiple as the key drivers behind the refreshed price targets.
KBHL
DKK 6,580.00
Københavns Lufthavne
7D
3.1%
1Y
3.1%